Your browser doesn't support javascript.
COVID-19 and Diagnostic Testing for SARS-CoV-2 by RT-qPCR-Facts and Fallacies.
Bustin, Stephen; Mueller, Reinhold; Shipley, Gregory; Nolan, Tania.
  • Bustin S; Medical Technology Research Centre, Anglia Ruskin University, Chelmsford CM1 1SQ, UK.
  • Mueller R; RM Consulting, San Diego, CA 92037, USA.
  • Shipley G; Shipley Consulting, Vancouver, WA 98682, USA.
  • Nolan T; Medical Technology Research Centre, Anglia Ruskin University, Chelmsford CM1 1SQ, UK.
Int J Mol Sci ; 22(5)2021 Feb 28.
Article in English | MEDLINE | ID: covidwho-1120492
ABSTRACT
Although molecular testing, and RT-qPCR in particular, has been an indispensable component in the scientific armoury targeting SARS-CoV-2, there are numerous falsehoods, misconceptions, assumptions and exaggerated expectations with regards to capability, performance and usefulness of the technology. It is essential that the true strengths and limitations, although publicised for at least twenty years, are restated in the context of the current COVID-19 epidemic. The main objective of this commentary is to address and help stop the unfounded and debilitating speculation surrounding its use.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Molecular Diagnostic Techniques / Real-Time Polymerase Chain Reaction / COVID-19 Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Ijms22052459

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Molecular Diagnostic Techniques / Real-Time Polymerase Chain Reaction / COVID-19 Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Year: 2021 Document Type: Article Affiliation country: Ijms22052459